Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-01 @ 12:52 AM
Study NCT ID:
NCT05011851
Status:
COMPLETED
Last Update Posted:
2025-01-31
First Post:
2021-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome
Sponsor:
Neuren Pharmaceuticals Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-16
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-05
First Submit QC Date:
None
Study First Post Date:
2021-08-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-08-07
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-01-29
Last Update Post Date:
2025-01-31
Last Update Post Date Type:
ACTUAL